PDF herunterladen
Endoscopy 2022; 54(05): 475-485
DOI: 10.1055/a-1637-9051
Original article

Endoscopic full-thickness resection of T1 colorectal cancers: a retrospective analysis from a multicenter Dutch eFTR registry

Liselotte W. Zwager‡   *
 1   Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, the Netherlands
,
Barbara A. J. Bastiaansen‡   *
 1   Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, the Netherlands
,
Bas W. van der Spek 
 2   Department of Gastroenterology and Hepatology, Noordwest Hospital Group, Alkmaar, the Netherlands
,
Dimitri N. Heine
 2   Department of Gastroenterology and Hepatology, Noordwest Hospital Group, Alkmaar, the Netherlands
,
Ramon M. Schreuder
 3   Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands
,
Lars E. Perk
 4   Department of Gastroenterology and Hepatology, Haaglanden Medical Center, the Hague, the Netherlands
,
Bas L. A. M. Weusten
 5   Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands
,
Jurjen J. Boonstra
 6   Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands
,
Hedwig van der Sluis
 7   Department of Gastroenterology and Hepatology, Isala Clinics, Zwolle, the Netherlands
,
Hugo J. Wolters
 8   Department of Gastroenterology and Hepatology, Martini Hospital, Groningen, the Netherlands
,
Frank C. Bekkering
 9   Department of Gastroenterology and Hepatology, IJsselland Hospital, Capelle aan den IJssel, the Netherlands
,
Svend T. Rietdijk
10   Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands
,
Matthijs P. Schwartz
11   Department of Gastroenterology and Hepatology, Meander Medical Center, Amersfoort, the Netherlands
,
Wouter B. Nagengast
12   Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
,
W. Rogier ten Hove
13   Department of Gastroenterology and Hepatology, Alrijne Medical Group, Leiden, the Netherlands
,
Jochim S. Terhaar sive Droste
14   Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, the Netherlands
,
Francisco J. Rando Munoz
15   Department of Gastroenterology and Hepatology, Nij Smellinghe Hospital, Drachten, the Netherlands
,
Marije S. Vlug
16   Department of Gastroenterology and Hepatology, Dijklander Hospital, Hoorn, the Netherlands
,
Hanneke Beaumont
17   Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, location VU, Amsterdam, the Netherlands
,
Martin H. M. G. Houben
18   Department of Gastroenterology and Hepatology, Haga Teaching Hospital, the Hague, the Netherlands
,
Tom C. J. Seerden
19   Department of Gastroenterology and Hepatology, Amphia Hospital, Breda, the Netherlands
,
Thomas R. de Wijkerslooth
20   Department of Gastroenterology and Hepatology, Antoni van Leeuwenhoek Hospital (NKI /AVL), Amsterdam, the Netherlands
,
Eric A. R. Gielisse
21   Department of Gastroenterology and Hepatology, Rode Kruis Hospital, Beverwijk, the Netherlands
,
Yark Hazewinkel
22   Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands
,
Rogier de Ridder
23   Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands
,
Jan-Willem A. Straathof
24   Department of Gastroenterology and Hepatology, Maxima Medical Center, Eindhoven, the Netherlands
,
Manon van der Vlugt
 1   Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, the Netherlands
,
Lianne Koens
25   Department of Pathology, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, The Netherlands
,
Paul Fockens
 1   Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, the Netherlands
,
Evelien Dekker
 1   Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, location AMC, Amsterdam Gastroenterology & Metabolism, University of Amsterdam, Amsterdam, the Netherlands
,
on behalf of the Dutch eFTR Group › InstitutsangabenTrial Registration: Netherlands National Trial Register Registration number (trial ID): NL5868 Type of study: Prospective multicenter study
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Einführung zu diesem Artikel:

Endoscopic full-thickness resection for T1 colorectal cancer: here to stay!Endoscopy 2022; 54(05): 486-487
DOI: 10.1055/a-1708-0166

Abstract

Background Complete endoscopic resection and accurate histological evaluation for T1 colorectal cancer (CRC) are critical in determining subsequent treatment. Endoscopic full-thickness resection (eFTR) is a new treatment option for T1 CRC < 2 cm. We aimed to report clinical outcomes and short-term results.

Methods Consecutive eFTR procedures for T1 CRC, prospectively recorded in our national registry between November 2015 and April 2020, were retrospectively analyzed. Primary outcomes were technical success and R0 resection. Secondary outcomes were histological risk assessment, curative resection, adverse events, and short-term outcomes.

Results We included 330 procedures: 132 primary resections and 198 secondary scar resections after incomplete T1 CRC resection. Overall technical success, R0 resection, and curative resection rates were 87.0 % (95 % confidence interval [CI] 82.7 %–90.3 %), 85.6 % (95 %CI 81.2 %–89.2 %), and 60.3 % (95 %CI 54.7 %–65.7 %). Curative resection rate was 23.7 % (95 %CI 15.9 %–33.6 %) for primary resection of T1 CRC and 60.8 % (95 %CI 50.4 %–70.4 %) after excluding deep submucosal invasion as a risk factor. Risk stratification was possible in 99.3 %. The severe adverse event rate was 2.2 %. Additional oncological surgery was performed in 49/320 (15.3 %), with residual cancer in 11/49 (22.4 %). Endoscopic follow-up was available in 200/242 (82.6 %), with a median of 4 months and residual cancer in 1 (0.5 %) following an incomplete resection.

Conclusions eFTR is relatively safe and effective for resection of small T1 CRC, both as primary and secondary treatment. eFTR can expand endoscopic treatment options for T1 CRC and could help to reduce surgical overtreatment. Future studies should focus on long-term outcomes.

* Both authors contributed equally to this article


Tables 1 s–4 s



Publikationsverlauf

Eingereicht: 02. April 2021

Angenommen: 06. September 2021

Accepted Manuscript online:
06. September 2021

Artikel online veröffentlicht:
11. Januar 2022

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Reggiani-Bonetti L, Di Gregorio C, Pedroni M. et al. Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. Scand J Gastroenterol 2013; 48: 1294-1301
    CrossrefPubMedSuche in Google Scholar
  • 2 Toes-Zoutendijk E, Kooyker AI, Elferink MA. et al. Stage distribution of screen-detected colorectal cancers in the Netherlands. Gut 2018; 67: 1745-1746
    CrossrefPubMedSuche in Google Scholar
  • 3 Kim JB, Lee HS, Lee HJ. et al. Long-term outcomes of endoscopic versus surgical resection of superficial submucosal colorectal cancer. Dig Dis Sci 2015; 60: 2785-2792
    CrossrefPubMedSuche in Google Scholar
  • 4 Vermeer NCA, Backes Y, Snijders HS. et al. National cohort study on postoperative risks after surgery for submucosal invasive colorectal cancer. BJS Open 2019; 3: 210-217
    CrossrefPubMedSuche in Google Scholar
  • 5 Ferlitsch M, Moss A, Hassan C. et al. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2017; 49: 270-297
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 Shaukat A, Kaltenbach T, Dominitz JA. et al. Endoscopic recognition and management strategies for malignant colorectal polyps: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2020; 115: 1751-1767
    CrossrefPubMedSuche in Google Scholar
  • 7 Beaton C, Twine CP, Williams GL. et al. Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis 2013; 15: 788-797
    CrossrefPubMedSuche in Google Scholar
  • 8 Ikematsu H, Yoda Y, Matsuda T. et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology 2013; 144: 551-559
    CrossrefPubMedSuche in Google Scholar
  • 9 Arezzo A, Passera R, Marchese N. et al. Systematic review and meta-analysis of endoscopic submucosal dissection vs endoscopic mucosal resection for colorectal lesions. United European Gastroenterol J 2016; 4: 18-29
    CrossrefPubMedSuche in Google Scholar
  • 10 Vleugels JLA, Koens L, Dijkgraaf MGW. et al. Suboptimal endoscopic cancer recognition in colorectal lesions in a national bowel screening programme. Gut 2020; 69: 977-980
    CrossrefPubMedSuche in Google Scholar
  • 11 Butte JM, Tang P, Gonen M. et al. Rate of residual disease after complete endoscopic resection of malignant colonic polyp. Dis Colon Rectum 2012; 55: 122-127
    CrossrefPubMedSuche in Google Scholar
  • 12 Schmidt A, Beyna T, Schumacher B. et al. Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications. Gut 2018; 67: 1280-1289
    CrossrefPubMedSuche in Google Scholar
  • 13 Velegraki M, Trikola A, Vasiliadis K. et al. Endoscopic full-thickness resection of colorectal lesions with the full-thickness resection device: clinical experience from two referral centers in Greece. Ann Gastroenterol 2019; 32: 482-488
    PubMedSuche in Google Scholar
  • 14 Aepli P, Criblez D, Baumeler S. et al. Endoscopic full thickness resection (EFTR) of colorectal neoplasms with the Full Thickness Resection Device (FTRD): Clinical experience from two tertiary referral centers in Switzerland. United European Gastroenterol J 2018; 6: 463-470
    CrossrefPubMedSuche in Google Scholar
  • 15 Valli PV, Mertens J, Bauerfeind P. Safe and successful resection of difficult GI lesions using a novel single-step full-thickness resection device (FTRD(). Surg Endosc 2018; 32: 289-299
    CrossrefPubMedSuche in Google Scholar
  • 16 Andrisani G, Pizzicannella M, Martino M. et al. Endoscopic full-thickness resection of superficial colorectal neoplasms using a new over-the-scope clip system: a single-centre study. Dig Liver Dis 2017; 49: 1009-1013
    CrossrefPubMedSuche in Google Scholar
  • 17 Vitali F, Naegel A, Siebler J. et al. Endoscopic full-thickness resection with an over-the-scope clip device (FTRD) in the colorectum: results from a university tertiary referral center. Endosc Int Open 2018; 6: E98-E103
    Thieme ConnectPubMedSuche in Google Scholar
  • 18 Meier B, Stritzke B, Kuellmer A. et al. Efficacy and safety of endoscopic full-thickness resection in the colorectum: results from the German Colonic FTRD Registry. Am J Gastroenterol 2020; 115: 1998-2006
    CrossrefPubMedSuche in Google Scholar
  • 19 Castor Electronic Data Capture. Amsterdam: 2019 https://www.castoredc.com Accessed: 2 April 2021
    PubMedSuche in Google Scholar
  • 20 Zwager LW, Bastiaansen BAJ, Bronzwaer MES. et al. Endoscopic full-thickness resection (eFTR) of colorectal lesions: results from the Dutch colorectal eFTR registry. Endoscopy 2020;
    Thieme ConnectPubMedSuche in Google Scholar
  • 21 Dutch Colorectal Cancer Guideline [In Dutch]. 2014 https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/startpagina_-_crc.html Accessed: 2 April 2021
    PubMedSuche in Google Scholar
  • 22 Yasue C, Chino A, Takamatsu M. et al. Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions. J Gastroenterol 2019; 54: 708-717
    CrossrefPubMedSuche in Google Scholar
  • 23 Nakadoi K, Tanaka S, Kanao H. et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol 2012; 27: 1057-1062
    CrossrefPubMedSuche in Google Scholar
  • 24 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
    CrossrefPubMedSuche in Google Scholar
  • 25 Kuellmer A, Mueller J, Caca K. et al. Endoscopic full-thickness resection for early colorectal cancer. Gastrointest Endosc 2019; 89: 1180-1189
    CrossrefPubMedSuche in Google Scholar
  • 26 Hassan C, Repici A, Sharma P. et al. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis. Gut 2016; 65: 806-820
    CrossrefPubMedSuche in Google Scholar
  • 27 Fuccio L, Repici A, Hassan C. et al. Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection. Gut 2018; 67: 1464-1474
    CrossrefPubMedSuche in Google Scholar
  • 28 Watanabe D, Toyonaga T, Ooi M. et al. Clinical outcomes of deep invasive submucosal colorectal cancer after ESD. Surg Endosc 2018; 32: 2123-2130
    CrossrefPubMedSuche in Google Scholar
  • 29 Tanaka S, Asayama N, Shigita K. et al. Towards safer and appropriate application of endoscopic submucosal dissection for T1 colorectal carcinoma as total excisional biopsy: future perspectives. Dig Endosc 2015; 27: 216-222
    CrossrefPubMedSuche in Google Scholar
  • 30 Park EY, Baek DH, Lee MW. et al. Long-term outcomes of T1 colorectal cancer after endoscopic resection. J Clin Med 2020; 9: 2451
    CrossrefPubMedSuche in Google Scholar
  • 31 Nishimura T, Oka S, Tanaka S. et al. Clinical significance of immunohistochemical lymphovascular evaluation to determine additional surgery after endoscopic submucosal dissection for colorectal T1 carcinoma. Int J Colorectal Dis 2020;
    CrossrefPubMedSuche in Google Scholar
  • 32 Sumimoto K, Tanaka S, Shigita K. et al. Diagnostic performance of Japan NBI Expert Team classification for differentiation among noninvasive, superficially invasive, and deeply invasive colorectal neoplasia. Gastrointest Endosc 2017; 86: 700-709
    CrossrefPubMedSuche in Google Scholar
  • 33 Richards CH, Ventham NT, Mansouri D. et al. An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS). Gut 2018; 67: 299-306
    CrossrefPubMedSuche in Google Scholar
  • 34 Fuccio L, Hassan C, Ponchon T. et al. Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis. Gastrointest Endosc 2017; 86: 74-86
    CrossrefPubMedSuche in Google Scholar
  • 35 Ohtsuki K, Koyama F, Tamura T. et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res 2008; 28: 1831-1836
    PubMedSuche in Google Scholar